ABSTRACT
BACKGROUND: New approaches on paediatric cancer treatment aim to maintain long-term health. As a result of radiotherapy, chemotherapy or surgery, paediatric cancer survivors tend to suffer from any chronic health condition. Endocrine dysfunction represents one of the most common issues and affects bone health. Exercise is key for bone mass accrual during growth, specifically plyometric jump training. The iBoneFIT study will investigate the effect of a 9-month online exercise programme on bone health in paediatric cancer survivors. This study will also examine the effect of the intervention on body composition, physical fitness, physical activity, calcium intake, vitamin D, blood samples quality of life and mental health. METHODS: A minimum of 116 participants aged 6 to 18 years will be randomized into an intervention (n = 58) or control group (n = 58). The intervention group will receive an online exercise programme and diet counselling on calcium and vitamin D. In addition, five behaviour change techniques and a gamification design will be implemented in order to increase the interest of this non-game programme. The control group will only receive diet counselling. Participants will be assessed on 3 occasions: 1) at baseline; 2) after the 9 months of the intervention; 3) 4 months following the intervention. The primary outcome will be determined by dual energy X-ray absorptiometry (DXA) and the hip structural analysis, trabecular bone score and 3D-DXA softwares. Secondary outcomes will include anthropometry, body composition, physical fitness, physical activity, calcium and vitamin D intake, blood samples, quality of life and mental health. DISCUSSION: Whether a simple, feasible and short in duration exercise programme can improve bone health has not been examined in paediatric cancer survivors. This article describes the design, rationale and methods of a study intended to test the effect of a rigorous online exercise programme on bone health in paediatric cancer survivors. If successful, the iBoneFIT study will contribute to decrease chronic health conditions in this population and will have a positive impact in the society. TRIAL REGISTRATION: Prospectively registered in isrctn.com: isrctn61195625 . Registered 2 April 2020.
Subject(s)
Bone Density , Cancer Survivors/statistics & numerical data , Exercise Therapy/methods , Telemedicine , Adolescent , Child , Female , Humans , Male , Program Evaluation , Research DesignABSTRACT
Hereditary punctate palmoplantar keratoderma or Buschke-Fisher-Brauer disease is a rare form of keratoderma that follows a pattern of autosomal dominant inheritance with variable penetrance. The age of onset is usually between 12 and 30 years of age. Clinically, it is characterized by the gradual appearance of multiple punctate hyperkeratotic papules, irregularly distributed on the palms and soles, as well as by its possible association with several diseases, primarily with malignant processes. We present the case of a 43-year-old male patient with this disease, with no other associated symptoms, who had a first-degree relative who was affected and died of colon cancer. We also discuss the differential diagnosis with other nosologic entities.
Subject(s)
Keratoderma, Palmoplantar/diagnosis , Adult , Genes, Dominant , Humans , Keratoderma, Palmoplantar/classification , Keratoderma, Palmoplantar/pathology , MaleABSTRACT
La queratodermia palmoplantar punctata hereditaria o enfermedad de Buschke-Fisher-Brauer es una forma poco frecuente de queratodermia que sigue un patrón de herencia autosómico dominante con penetrancia variable. La edad de inicio suele estar comprendida entre los 12 y los 30 años de edad. Clínicamente se caracteriza por la aparición progresiva de múltiples pápulas hiperqueratósicas puntiformes de distribución irregular a nivel de palmas y plantas así como por su posible asociación con diversas enfermedades, fundamentalmente con procesos malignos. Presentamos un paciente de 43 años con esta enfermedad, sin otra sintomatología asociada, que tenía un familiar de primer grado afectado y fallecido de cáncer de colon, y planteamos el diagnóstico diferencial con otras entidades nosológicas
Hereditary punctate palmoplantar keratoderma or Buschke-Fisher-Brauer disease is a rare form of keratoderma that follows a pattern of autosomal dominant inheritance with variable penetrance. The age of onset is usually between 12 and 30 years of age. Clinically, it is characterized by the gradual appearance of multiple punctate hyperkeratotic papules, irregularly distributed on the palms and soles, as well as by its possible association with several diseases, primarily with malignant processes. We present the case of a 43-year-old male patient with this disease, with no other associated symptoms, who had a first-degree relative who was affected and died of colon cancer. We also discuss the differential diagnosis with other nosologic entities
Subject(s)
Male , Adult , Humans , Keratoderma, Palmoplantar/diagnosis , Keratoderma, Palmoplantar/drug therapy , Acanthosis Nigricans/complications , Acanthosis Nigricans/diagnosis , Biomarkers/analysis , Calcitriol/therapeutic use , Cholecalciferol/therapeutic use , Keratolytic Agents/therapeutic use , Retinoids/therapeutic use , Diagnosis, Differential , Colchicine/adverse effects , Vitamin D/therapeutic useABSTRACT
No disponible
No disponible
Subject(s)
Female , Adult , Humans , Skin Diseases, Vesiculobullous/pathology , Hand Dermatoses/pathology , Porphyrias, Hepatic/pathology , Porphobilinogen/urine , Diagnosis, Differential , Aminolevulinic Acid/urineABSTRACT
No disponible
